{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T09:11:38Z","timestamp":1781082698786,"version":"3.54.1"},"reference-count":40,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.3201\/eid2407.161783","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T12:52:52Z","timestamp":1526993572000},"page":"1267-1274","source":"Crossref","is-referenced-by-count":16,"title":["Registry Cohort Study to Determine Risk for Multiple Sclerosis after Vaccination for Pandemic Influenza A(H1N1) with Arepanrix, Manitoba, Canada"],"prefix":"10.3201","volume":"24","author":[{"given":"Salaheddin M.","family":"Mahmud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songul","family":"Bozat-Emre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz C.","family":"Mosta\u00e7o-Guidolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth Ann","family":"Marrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2407.161783-201806151226-R1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000110351","article-title":"How many people in the world have multiple sclerosis?","volume":"13","author":"Dean","year":"1994","journal-title":"Neuroepidemiology"},{"key":"key-10.3201\/eid2407.161783-201806151226-R2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S1474-4422(04)00933-0","article-title":"Environmental risk factors in multiple sclerosis aetiology.","volume":"3","author":"Marrie","year":"2004","journal-title":"Lancet Neurol"},{"key":"key-10.3201\/eid2407.161783-201806151226-R3","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1159\/000110781","article-title":"Measles vaccination does not prevent multiple sclerosis.","volume":"9","author":"Bansil","year":"1990","journal-title":"Neuroepidemiology"},{"key":"key-10.3201\/eid2407.161783-201806151226-R4","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1159\/000110369","article-title":"Environmental risk factors and multiple sclerosis: a community-based, case-control study in the province of Ferrara, Italy.","volume":"13","author":"Casetta","year":"1994","journal-title":"Neuroepidemiology"},{"key":"key-10.3201\/eid2407.161783-201806151226-R5","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1001\/archneur.1996.00550120018007","article-title":"Measles vaccination has had no effect on the occurrence of multiple sclerosis.","volume":"53","author":"Currier","year":"1996","journal-title":"Arch Neurol"},{"key":"key-10.3201\/eid2407.161783-201806151226-R6","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s10072-003-0147-6","article-title":"Risk factors of multiple sclerosis: a case-control study.","volume":"24","author":"Zorzon","year":"2003","journal-title":"Neurol Sci"},{"key":"key-10.3201\/eid2407.161783-201806151226-R7","doi-asserted-by":"publisher","first-page":"e7594","DOI":"10.1136\/bmj.e7594","article-title":"Risk of presentation to hospital with epileptic seizures after vaccination with monovalent AS03 adjuvanted pandemic A\/H1N1 2009 influenza vaccine (Pandemrix): self controlled case series study.","volume":"345","author":"Arnheim-Dahlstr\u00f6m","year":"2012","journal-title":"BMJ"},{"key":"key-10.3201\/eid2407.161783-201806151226-R8","doi-asserted-by":"publisher","first-page":"d5956","DOI":"10.1136\/bmj.d5956","article-title":"Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden.","volume":"343","author":"Bardage","year":"2011","journal-title":"BMJ"},{"key":"key-10.3201\/eid2407.161783-201806151226-R9","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1750-2659.2011.00229.x","article-title":"Immunogenicity and safety of pandemic influenza A (H1N1) 2009 vaccine: systematic review and meta-analysis.","volume":"5","author":"Yin","year":"2011","journal-title":"Influenza Other Respi Viruses"},{"key":"key-10.3201\/eid2407.161783-201806151226-R10","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1212\/WNL.0b013e3181cf6ec0","article-title":"The rising prevalence and changing age distribution of multiple sclerosis in Manitoba.","volume":"74","author":"Marrie","year":"2010","journal-title":"Neurology"},{"key":"key-10.3201\/eid2407.161783-201806151226-R11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000342779","article-title":"Incidence and prevalence of multiple sclerosis in the Americas: a systematic review.","volume":"40","author":"Evans","year":"2013","journal-title":"Neuroepidemiology"},{"key":"key-10.3201\/eid2407.161783-201806151226-R12","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/00005650-199303000-00002","article-title":"Registries and administrative data: organization and accuracy.","volume":"31","author":"Roos","year":"1993","journal-title":"Med Care"},{"key":"key-10.3201\/eid2407.161783-201806151226-R13","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.2105\/AJPH.84.10.1666","article-title":"Monitoring childhood immunizations: a Canadian approach.","volume":"84","author":"Roberts","year":"1994","journal-title":"Am J Public Health"},{"key":"key-10.3201\/eid2407.161783-201806151226-R14","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1345\/aph.18117","article-title":"Validation of an electronic, population-based prescription database.","volume":"32","author":"Kozyrskyj","year":"1998","journal-title":"Ann Pharmacother"},{"key":"key-10.3201\/eid2407.161783-201806151226-R15","doi-asserted-by":"publisher","first-page":"7975","DOI":"10.1016\/j.vaccine.2011.08.068","article-title":"Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: population-based case-control study.","volume":"29","author":"Mahmud","year":"2011","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2407.161783-201806151226-R16","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/EDE.0b013e3181a663cc","article-title":"High-dimensional propensity score adjustment in studies of treatment effects using health care claims data.","volume":"20","author":"Schneeweiss","year":"2009","journal-title":"Epidemiology"},{"key":"key-10.3201\/eid2407.161783-201806151226-R17","doi-asserted-by":"publisher","first-page":"757","DOI":"10.7326\/0003-4819-127-8_Part_2-199710151-00064","article-title":"Estimating causal effects from large data sets using propensity scores.","volume":"127","author":"Rubin","year":"1997","journal-title":"Ann Intern Med"},{"key":"key-10.3201\/eid2407.161783-201806151226-R18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.24095\/hpcdp.34.2\/3.09","article-title":"Performance of administrative case definitions for comorbidity in multiple sclerosis in Manitoba and Nova Scotia.","volume":"34","author":"Marrie","year":"2014","journal-title":"Chronic Dis Inj Can"},{"key":"key-10.3201\/eid2407.161783-201806151226-R19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data.","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"key-10.3201\/eid2407.161783-201806151226-R20","unstructured":"Lix L, Yogendran M, Burchill C, Metge C, McKeen N, Moore D, Defining and validating chronic diseases: an administrative data approach. Winnipeg: Manitoba Centre for Health Policy; 2006."},{"key":"key-10.3201\/eid2407.161783-201806151226-R21","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1002\/pds.935","article-title":"Strategies for identifying pregnancies in the automated medical records of the General Practice Research Database.","volume":"13","author":"Hardy","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"key-10.3201\/eid2407.161783-201806151226-R22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/epirev\/mxg002","article-title":"Matched cohort methods for injury research.","volume":"25","author":"Cummings","year":"2003","journal-title":"Epidemiol Rev"},{"key":"key-10.3201\/eid2407.161783-201806151226-R23","doi-asserted-by":"crossref","unstructured":"Therneau TM, Grambsch PM. Modeling survival data: extending the Cox model. New York: Springer; 2000.","DOI":"10.1007\/978-1-4757-3294-8"},{"key":"key-10.3201\/eid2407.161783-201806151226-R24","unstructured":"Fleiss JL, Levin B, Paik MC. Statistical methods for rates and proportions. 3rd ed. Hoboken (NJ): Wiley Interscience; 2013."},{"key":"key-10.3201\/eid2407.161783-201806151226-R25","doi-asserted-by":"publisher","first-page":"e24384","DOI":"10.1371\/journal.pone.0024384","article-title":"Meta-analysis of the immunogenicity and tolerability of pandemic influenza A 2009 (H1N1) vaccines.","volume":"6","author":"Manzoli","year":"2011","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2407.161783-201806151226-R26","doi-asserted-by":"publisher","first-page":"7123","DOI":"10.1016\/j.vaccine.2012.09.032","article-title":"Autoimmune disorders after immunisation with Influenza A\/H1N1 vaccines with and without adjuvant: EudraVigilance data and literature review.","volume":"30","author":"Isai","year":"2012","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2407.161783-201806151226-R27","doi-asserted-by":"publisher","first-page":"8302","DOI":"10.1016\/j.vaccine.2011.08.093","article-title":"Causality assessment of serious neurologic adverse events following 2009 H1N1 vaccination.","volume":"29","author":"Williams","year":"2011","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2407.161783-201806151226-R28","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/joim.12150","article-title":"Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population- and registry-based cohort study with over 2 years of follow-up.","volume":"275","author":"Persson","year":"2014","journal-title":"J Intern Med"},{"key":"key-10.3201\/eid2407.161783-201806151226-R29","doi-asserted-by":"publisher","first-page":"851","DOI":"10.4161\/hv.19917","article-title":"Effectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly: a critical review and re-analysis of 15 meta-analyses.","volume":"8","author":"Manzoli","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"key-10.3201\/eid2407.161783-201806151226-R30","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00415-011-5984-2","article-title":"Immunizations and risk of multiple sclerosis: systematic review and meta-analysis.","volume":"258","author":"Farez","year":"2011","journal-title":"J Neurol"},{"key":"key-10.3201\/eid2407.161783-201806151226-R31","doi-asserted-by":"publisher","first-page":"S546","DOI":"10.1093\/infdis\/136.Supplement_3.S546","article-title":"Swine influenza virus vaccination in patients with multiple sclerosis.","volume":"136","author":"Myers","year":"1977","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2407.161783-201806151226-R32","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1001\/archneur.1978.00500280060012","article-title":"Swine influenza vaccination in patients with multiple sclerosis.","volume":"35","author":"Bamford","year":"1978","journal-title":"Arch Neurol"},{"key":"key-10.3201\/eid2407.161783-201806151226-R33","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1007\/s00415-011-5944-x","article-title":"Relapse risk in patients with multiple sclerosis after H1N1 vaccination, with or without seasonal influenza vaccination.","volume":"258","author":"McNicholas","year":"2011","journal-title":"J Neurol"},{"key":"key-10.3201\/eid2407.161783-201806151226-R34","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1177\/1352458511417253","article-title":"H1N1 vaccination does not increase risk of relapse in multiple sclerosis: a self-controlled case-series study.","volume":"18","author":"Farez","year":"2012","journal-title":"Mult Scler"},{"key":"key-10.3201\/eid2407.161783-201806151226-R35","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1056\/NEJM200102013440501","article-title":"Vaccinations and the risk of relapse in multiple sclerosis.","volume":"344","author":"Confavreux","year":"2001","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2407.161783-201806151226-R36","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1212\/WNL.59.12.1837","article-title":"Immunization and MS: a summary of published evidence and recommendations.","volume":"59","author":"Rutschmann","year":"2002","journal-title":"Neurology"},{"key":"key-10.3201\/eid2407.161783-201806151226-R37","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.autrev.2013.03.012","article-title":"A literature review on optic neuritis following vaccination against virus infections.","volume":"12","author":"St\u00fcbgen","year":"2013","journal-title":"Autoimmun Rev"},{"key":"key-10.3201\/eid2407.161783-201806151226-R38","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1001\/jamaneurol.2014.2633","article-title":"Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases.","volume":"71","author":"Langer-Gould","year":"2014","journal-title":"JAMA Neurol"},{"key":"key-10.3201\/eid2407.161783-201806151226-R39","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1212\/01.wnl.0000178891.20579.64","article-title":"Changes in the ascertainment of multiple sclerosis.","volume":"65","author":"Marrie","year":"2005","journal-title":"Neurology"},{"key":"key-10.3201\/eid2407.161783-201806151226-R40","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2377-13-128","article-title":"Incidence and prevalence of multiple sclerosis in Europe: a systematic review.","volume":"13","author":"Kingwell","year":"2013","journal-title":"BMC Neurol"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/24\/7\/16-1783_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T17:23:59Z","timestamp":1732987439000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/24\/7\/16-1783_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2407.161783","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7]]}}}